Skip to main content
Equibles

AMERIPRISE FINANCIAL INC

Position in AVXL — Anavex Life Sciences Corp.

CIK 820027 MINNEAPOLIS, MN
Back to AVXL Full portfolio

Position in AVXL

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$153,055
-$75,269 QoQ
Shares Held
59,095
-20.5% QoQ
Ownership
0.064%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#55
of 179 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in AVXL Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

AMERIPRISE FINANCIAL INC holds $5,060,262,064 across 202 Biotechnology names. AVXL ranks #192 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 2,604,822 $1,293,893,227
2 INSM
INSMED Inc
 6,179,571 $658,865,856
3 JAZZ
Jazz Pharmaceuticals plc
 1,215,523 $292,904,576
4 RVMD
Revolution Medicines, Inc.
 1,039,702 $194,715,388
5 ARGX
Argenx SE
 181,464 $168,356,853
6 REGN
Regeneron Pharmaceuticals, Inc.
 227,457 $141,828,535
7 MDGL
Madrigal Pharmaceuticals, Inc.
 231,205 $124,145,521
8 BBIO
BridgeBio Pharma, Inc.
 1,551,663 $115,567,858

All Filings in AVXL

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $153,055 59,095
2026-03-31 $228,324 74,373
2025-12-31 $243,948 68,525
2025-09-30 $763,575 85,795
2025-06-30 $792,827 85,990
2025-03-31 $727,214 84,757
2024-12-31 $717,538 66,810
2024-09-30 $361,060 63,567
2024-06-30 $267,894 63,482
2024-03-31 $326,839 64,212
2023-12-31 $508,809 54,652
2023-09-30 $238,256 36,375
2023-06-30 $272,037 33,461
2023-03-31 $286,888 33,476
2022-12-31 $311,598 33,650
2022-09-30 $203,871 19,755
2022-06-30 $174,223 17,405
2022-03-31 $210,562 17,105
2021-12-31 $398,212 22,965
2021-09-30 $645,571 35,965
2021-06-30 $1,420,977 62,160
2021-03-31 $1,392,218 93,125
2020-12-31 $369,360 68,400
2020-09-30 $149,034 32,755
2020-06-30 $74,144 15,070
2020-03-31 $52,935 16,805